Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International, Inc. (NASDAQ: BKYI) is an identity and access management (IAM) and biometric authentication company whose news flow centers on product innovation, strategic partnerships, investor communications, and capital markets activity. Press releases describe BIO-key as a biometric-centric, multi-factor IAM provider enabling phoneless, tokenless, passwordless, and phishing-resistant authentication for enterprise and large-scale identity deployments.
On this page, readers can follow updates on BIO-key’s participation in industry conferences and investor events, such as the Gartner Identity & Access Management Summit, the Africa Tech Festival, and the DealFlow Discovery investor conference. These announcements often highlight new passwordless capabilities, identity-bound biometric technologies, and demonstrations of the PortalGuard IAM platform.
Company news also covers strategic partnerships that extend BIO-key’s reach in key regions. Recent releases describe collaborations with SAVIS Group in Vietnam, VaporVM in the Middle East and Africa, and Cloud Distribution in Saudi Arabia. Through these relationships, BIO-key’s IAM and biometric solutions are integrated into broader cybersecurity and digital transformation offerings for enterprises, government agencies, and institutions.
Investors can track earnings-related communications and balance sheet updates through quarterly results announcements and associated investor calls. BIO-key’s news includes details on hardware launches such as the EcoID III fingerprint scanner, as well as disclosures about warrant exercise agreements and secured promissory notes that affect the company’s capital structure.
By monitoring the BKYI news feed, users can see how BIO-key positions its biometric and IAM technologies in sectors such as defense, finance, government, and education, and stay informed about material events reported in press releases that complement the company’s formal SEC filings.
BIO-key International, Inc. (Nasdaq: BKYI) reported a 96% revenue increase to $1.9M for Q2 2022, driven by higher software license fees and growth in hardware and services revenue. The company achieved a gross profit of $1.2M but saw a decline in gross profit margin to 63%. Total operating expenses rose to $2.8M, leading to a net loss of $1.7M, or $0.21 per share. Despite these losses, BIO-key anticipates full-year revenue guidance of $10-13M, aiming for more than 100% growth over 2021.
BIO-key International (NASDAQ: BKYI) will hold a conference call on August 12, 2022, at 10 a.m. ET to discuss its Q2 results, which will be released pre-market. The call will feature management members including Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO. For those unable to attend live, an investor webcast will be available for three months following the call. BIO-key provides innovative identity and access management solutions, focusing on Identity-Bound Biometrics.
BIO-key International (NASDAQ: BKYI) has renewed its partnership with Long Island University (LIU), extending a relationship that began in 2015. LIU, which has around 15,000 students across two campuses, will continue utilizing the PortalGuard Identity and Access Management (IAM) platform to enhance its security against rising cyber threats in the education sector. The renewed agreement aims to provide cost-effective security solutions, including multi-factor authentication and single sign-on capabilities, while also leveraging existing security investments.
BIO-key International, Inc. (NASDAQ: BKYI) announced its partnership with Darksteel Technologies, a Managed Security Service Provider, to implement its PortalGuard Identity-as-a-Service (IDaaS) platform. The collaboration aims to enhance security for Darksteel's small-to-medium-sized clients by providing advanced identity authentication solutions, including multi-factor authentication and self-service password resets. Carlos Cisneros from Darksteel praised BIO-key’s offerings and expressed optimism for a long-term relationship.
BIO-key International, Inc. (NASDAQ: BKYI) announced its sponsorship and exhibition at the NACo Annual Conference, taking place from July 20-24, 2022, in Aurora, Colorado. Kimberly Biddings, VP of Product, will serve as an expert panelist discussing cybersecurity during the CIO Forum. With counties facing numerous cyberattacks, BIO-key aims to enhance cybersecurity through its PortalGuard IAM platform, offering unique Identity-Bound Biometric (IBB) authentication. Attendees can explore live demonstrations at Booth 507 and engage in discussions on multi-factor authentication, remote access security, and election security.
BIO-key International, Inc. (NASDAQ: BKYI) announced that its PortalGuard® Identity-as-a-Service (IDaaS) platform has won the "Identity Management Solution of the Year" award at the 2022 RemoteTech Breakthrough Awards, marking the second consecutive year of recognition. The award highlights PortalGuard's capabilities in securing remote access amidst rising demand for hybrid work environments. The platform's biometric features enhance security by verifying user identity, addressing vulnerabilities seen in traditional multi-factor authentication methods. The RemoteTech Breakthrough Awards evaluated over 1,700 nominations globally.
BIO-key International, Inc. (BKYI) will display its Identity and Access Management solutions at MSP EXPO from June 21-24, 2022, in Fort Lauderdale, Florida. The company aims to enhance its partnerships with Managed Service Providers (MSPs) and Managed Security Service Providers (MSSPs) through its Channel Alliance Partner Program. BIO-key promotes its PortalGuard IAM platform to offer innovative cybersecurity solutions, addressing the rising demand due to increased cyberattacks and the need for multi-factor authentication. Key benefits include building recurring revenue and fostering customer relationships.
BIO-key International (NASDAQ: BKYI) announced its membership in the Amazon Web Services (AWS) Partner Network on June 21, 2022. This partnership aims to enhance identity and access management (IAM) solutions in the cloud, promoting scalability and reduced operational overhead. BIO-key will benefit from the AWS ISV Accelerate Program, allowing faster sales cycles by co-selling with AWS. Customers like Allan Hancock College and Orange Bank & Trust Company have successfully transitioned to BIO-key's PortalGuard IDaaS, realizing significant operational efficiencies and cost reductions.
Summary not available.
Summary not available.